I agree that this site is using cookies. You can find further informations here.
X
Guinn, Daphne
28  results:
Search for persons X
?
1

Assessing Pharmacokinetics in Liver Disease: Challenges and..:

Sahre, Martina D. ; Guinn, Daphne ; Ramamoorthy, Anuradha...
The Journal of Clinical Pharmacology.  63 (2023)  7 - p. 755-758 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Pharmacokinetic Evaluation in Pregnancy—Current Status and ..:

Guinn, Daphne ; Sahin, Leyla ; Fletcher, Elimika Pfuma...
The Journal of Clinical Pharmacology.  63 (2023)  S1 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
3

Informing a Comprehensive Risk Assessment of Infant Drug Ex..:

Pressly, Michelle A. ; Schmidt, Stephan ; Guinn, Daphne...
The Journal of Clinical Pharmacology.  63 (2023)  S1 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
4

US FDA Postmarketing Requirements and Commitments: A System..:

Ridge, Sarah ; Guinn, Daphne ; Pfuma Fletcher, Elimika...
The Journal of Clinical Pharmacology.  63 (2023)  6 - p. 695-703 , 2023
Link: https://doi.org/10.1002/..
 
?
5

Assessing Information Gaps Associated with Initial Pediatri..:

Guinn, Daphne ; Gafford, Marilyn ; Burckart, Gilbert J...
Clinical Pharmacology & Therapeutics.  114 (2023)  3 - p. 618-622 , 2023
Link: https://doi.org/10.1002/..
 
?
6

Efficiency of a randomized confirmatory basket trial design..:

He, Linchen ; Ren, Yuru ; Chen, Han...
Statistical Methods in Medical Research.  31 (2022)  7 - p. 1207-1223 , 2022
Link: https://doi.org/10.1177/..
 
?
7

Exploring the Knowledge Gaps in Infant Drug Exposure From H..:

Guinn, Daphne ; Pressly, Michelle A. ; Liu, Zhichao...
The Journal of Clinical Pharmacology.  63 (2022)  3 - p. 273-276 , 2022
Link: https://doi.org/10.1002/..
 
?
8

Roadmap to 2030 for Drug Evaluation in Older Adults:

Liu, Qi ; Schwartz, Janice B. ; Slattum, Patricia W....
Clinical Pharmacology & Therapeutics.  112 (2021)  2 - p. 210-223 , 2021
Link: https://doi.org/10.1002/..
 
?
9

Elucidating the Impact of Immunogenicity Assessment Postapp..:

Guinn, Daphne ; Madabushi, Rajanikanth ; Wang, Yow‐Ming..
Clinical Pharmacology & Therapeutics.  109 (2020)  3 - p. 697-704 , 2020
Link: https://doi.org/10.1002/..
 
?
10

Communicating Immunogenicity-Associated Risk in Current U.S..:

Guinn, Daphne ; Madabushi, Rajanikanth ; Wang, Yow-Ming...
Therapeutic Innovation & Regulatory Science.  54 (2020)  6 - p. 1363-1371 , 2020
Link: https://doi.org/10.1007/..
 
?
11

Reasons for Premature Conclusion of Late Phase Clinical Tri..:

Guinn, Daphne ; Wilhelm, Erin E. ; Shoulson, Ira
Therapeutic Innovation & Regulatory Science.  54 (2020)  1 - p. 232-239 , 2020
Link: https://doi.org/10.1007/..
 
?
12

A Systematic Assessment of US Food and Drug Administration ..:

Wang, Lingshan ; Maxfield, Kimberly ; Guinn, Daphne...
Clinical Pharmacology & Therapeutics.  109 (2020)  1 - p. 123-130 , 2020
Link: https://doi.org/10.1002/..
 
?
13

Reasons for Premature Conclusion of Late Phase Clinical Tri..:

Guinn, Daphne ; Wilhelm, Erin E. ; Shoulson, Ira
Therapeutic Innovation & Regulatory Science.  , 2019
Link: https://doi.org/10.1177/..
 
?
14

Harnessing Real-World Data to Inform Platform Trial Design:

, In: Platform Trial Designs in Drug Development,
Guinn, Daphne ; Madhavan, Subha ; Beckman, Robert A. - p. 55-72 , 2018
Link: https://doi.org/10.1201/..
 
?
15

The regulation of tumor‐suppressive microRNA, miR‐126, in c..:

Guinn, Daphne ; Lehman, Amy ; Fabian, Catherine...
Cancer Medicine.  6 (2017)  4 - p. 778-787 , 2017
Link: https://doi.org/10.1002/..
 
1-15